These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
728 related articles for article (PubMed ID: 23082061)
1. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients. Guo J; Dong B; Ji JF; Wu AW World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061 [TBL] [Abstract][Full Text] [Related]
2. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer. He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer. Guo J; Zu G; Zhou T; Xing J; Wang Z Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133 [TBL] [Abstract][Full Text] [Related]
4. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma. Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140 [TBL] [Abstract][Full Text] [Related]
5. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma. Shi R; Wang L; Wang T; Xu J; Wang F; Xu M Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954 [TBL] [Abstract][Full Text] [Related]
6. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645 [TBL] [Abstract][Full Text] [Related]
7. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma. Tang C; Gao X; Liu H; Jiang T; Zhai X Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349 [TBL] [Abstract][Full Text] [Related]
8. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis. Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295 [TBL] [Abstract][Full Text] [Related]
9. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas. Zhao Y; Zhang T; Wang Q Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849 [TBL] [Abstract][Full Text] [Related]
10. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [TBL] [Abstract][Full Text] [Related]
11. Expression and prognosis of MYOZ2 in gastric cancer. Li YF; Zhu GY; Ma Y; Qu HY Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5920-5927. PubMed ID: 30280773 [TBL] [Abstract][Full Text] [Related]
12. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
13. Beclin 1 expression is an independent prognostic factor for gastric carcinomas. Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926 [TBL] [Abstract][Full Text] [Related]
14. Dickkopf-1 expression is a novel prognostic marker for gastric cancer. Gao C; Xie R; Ren C; Yang X J Biomed Biotechnol; 2012; 2012():804592. PubMed ID: 22496615 [TBL] [Abstract][Full Text] [Related]
15. Low SOX12 Expression Is Correlated With Poor Prognosis in Patients With Gastric Cancer. Yang KK; Xu HM; Huang JY; Guo YX; Wang ZN Technol Cancer Res Treat; 2020; 19():1533033819901126. PubMed ID: 32019439 [TBL] [Abstract][Full Text] [Related]
16. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer. Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer. Jiao X; Lu HJ; Zhai MM; Tan ZJ; Zhi HN; Liu XM; Liu CH; Zhang DP World J Gastroenterol; 2013 Dec; 19(48):9425-31. PubMed ID: 24409072 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma. Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878 [TBL] [Abstract][Full Text] [Related]
19. Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer. Luo D; Lu ML; Zhao GF; Huang H; Zheng MY; Chang J; Lv L; Luo JB World J Gastroenterol; 2012 May; 18(19):2423-9. PubMed ID: 22654436 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]